Once-weekly semaglutide versus placebo in adults with increased fracture risk: A randomised, double-blinded, two-centre, phase 2 trial
These concepts are still experimental, but the science is moving toward tailoring immune cell metabolism ex vivo and then using those cells as a therapy
For instance, those with high physical activity may benefit from slightly higher doses, whereas people with pre-existing medical conditions may need to lower the dosage accordingly
Could have systemic side effects
Cc l chn lng b tc ny l ni vi khun gy mn, vi khun Propionibacterium Acnes c th sinh si, dn n mn v vt thm
Cht lng sn phm rt tt vi nguyn liu nhp khu t Nht Bn v tinh khit cao